SCHEMBL23005035

SCHEMBL23005035

CC(C)(C)OC(=O)N(Cc1ccccc1)C(C=O)CC1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.45
HTR2C P28335 3/20 0.41
SLC6A4 P31645 3/20 0.41
REN P00797 5/20 0.40
L3MBTL1 Q9Y468 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HSD11B1 P28845 1/20 0.37
NPY5R Q15761 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
HSD17B10 Q99714 1/20 0.37
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
AKT1 P31749 2/20 0.37
YAP1 P46937 1/20 0.37
TEAD4 Q15561 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23022839 0.85 ATM (0.47) ATMHTR2CSLC6A4RENL3MBTL1
SCHEMBL2736195 0.81 ATM (0.43) ATML3MBTL1ALDH1A1LMNAPOLB
SCHEMBL2736205 0.79 HDAC3 (0.45) ATMHTR2CSLC6A4L3MBTL1ALDH1A1
SCHEMBL1864932 0.79 REN (0.44) ATMHTR2CSLC6A4RENL3MBTL1
SCHEMBL3817673 0.78 JAK2 (0.44) ATML3MBTL1HSD11B1ALDH1A1LMNA
SCHEMBL1424364 0.76 CTSK (0.40) HTR2CSLC6A4RENNPY5R
SCHEMBL8292676 0.76 ATM (0.47) ATML3MBTL1NPC1RAB9AALDH1A1
SCHEMBL1864929 0.74 REN (0.53) REN
SCHEMBL25852154 0.73 KMT2A (0.59) ATML3MBTL1ALDH1A1LMNAPOLB
SCHEMBL3915529 0.73 BCHE (0.42) ATMHTR2CSLC6A4REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230102879-A1 TRNA SYNTHETASE INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2023-03-30 US disclosed
US-11261201-B2 TRNA synthetase inhibitors PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2022-03-01 US disclosed
US-20210053997-A1 TRNA SYNTHETASE INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2021-02-25 US disclosed
US-20210053997-A1 TRNA SYNTHETASE INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2021-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210053997-A1 TRNA SYNTHETASE INHIBITORS TRMT1, AARS1, GARS1 ATM 3472/4885HTR2C 4102/4885SLC6A4 2146/4885
US-20230102879-A1 TRNA SYNTHETASE INHIBITORS TRMT1, AARS1, GARS1 ATM 3472/4885HTR2C 4102/4885SLC6A4 2146/4885
US-11261201-B2 TRNA synthetase inhibitors TRMT1, AARS1, GARS1 ATM 3472/4885HTR2C 4102/4885SLC6A4 2146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.